Rottenstein Law Group Hopeful About New Use of Embattled Drug Fosamax
(New York, NY, August 29, 2011) The Rottenstein Law Group, which represents clients with claims of harm resulting from use of the osteoporosis drug Fosamax, notes with both optimism and skepticism a new report claiming the troubled drug might aid in the treatment of certain cancers.
According to a recent Reuters report, a new study “adds to evidence that bone drugs may play a role in suppressing cancer development, although there is still no proof that taking the medications would stave off malignancies.”
The drugs, known as bisphosphonates, the report continued, “have generated both good and bad headlines recently. Some work has linked them to fewer cases of cancer, while other research has found an increased risk of certain thigh fractures and serious jaw problems among women who take the drugs to treat the bone-thinning disease osteoporosis. Bone drugs on the market include Merck’s Fosamax, Roche’s Boniva, Novartis’s Reclast and Warner Chilcott’s Actonel.”
In the new study, Reuters reports that women on Actonel “were only half as likely to be diagnosed with colon cancer as those who’d gotten just one prescription for the drug or none at all. ‘At this point, I think people who are already taking the drug can be reassured,’ Dr. Harminder Singh, who worked on the study, told Reuters Health. But he added that it’s too soon to think about taking Actonel to prevent cancer.”
The U.S. Food and Drug Administration (FDA) issued a Fosamax warning in October 2010, stating that it and other bisphosphonates causes atypical low-impact femur fractures. Consequently, numerous lawsuits have been filed against the manufacturer in several federal courts. The suits allege, among other things, that Merck did not adequately test the drug and then failed to warn consumers of its dangers.
The Rottenstein Law Group advises anyone with a friend or family member who has been prescribed Fosamax or another osteoporosis drug to recommend to that person that he or she consult a physician immediately, then speak to a qualified Fosamax lawyer. The Rottenstein Law Group lawyers have a total of more than 25 years of experience fighting for the rights of clients who have suffered harm due to the negligence of powerful corporations. Affected individuals are advised to keep apprised of the latest news concerning the Fosamax femur fracture lawsuits by checking the Fosamax Femur Fracture Lawsuit Information Center for updated information. The site is equipped with easy-to-use social media features which will enable users to spread the word about the dangers of Fosamax.
About the Rottenstein Law Group
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, a lawyer with over two decades of experience in compassionate representation of clients in consumer product injury, mass tort, and class action law suits. For more information, please visit their Web site, or call (888) 9-ROT-LAW.
- Contact Information
- Nava Brahe
- PR Manager
- The Rottenstein Law Group
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.